Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's Disease
Clinical trial NCT00209014 · TERMINATED
Trial details
- NCT number
- NCT00209014
- Sponsor
- Emory University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.